The Clinical Operations team at Reneo Pharmaceuticals is responsible for overseeing the design, execution, and management of clinical trials aimed at evaluating new therapies for genetic mitochondrial diseases. The team ensures compliance with regulatory standards, coordinates with cross-functional partners, and monitors trial progress to ensure safe and effective treatments are delivered to patients. By leveraging expertise in clinical affairs and toxicology, they strive to advance Reneo's innovative solutions from development to successful regulatory approval.
View all